Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Identification of MicroRNAs
 Statistical Process Control
 Kinase Inhibitor Therapies
Nov 2018   e-Newsletter Archives    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
Qatar Cargo
News
LEO Pharma and PellePharm Announce $760 Million Collaboration...
WuXi Biologics Commenced Construction of 1.6 million sq.ft Biologics Innovation...
Genentech Acquires Jecure Therapeutics ...
 
Press Releases
FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough...
Sandoz and Pear Therapeutics Announce Launch of reSET® for...
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the...
 
Events
03 -05 Dec 2018
1st RNA Targeted Drug Discovery Summit
05 -06 Dec 2018
Pharma Congress 2018
11 -11 Dec 2018
13th Biosimilars Congregation 2018
14 -16 Dec 2018
Myanmar Lab Expo 2018
Articles
  Identification of MicroRNAs and Their Targets in Cancer
Noor Hasima, Professor, Institute of Biological Sciences and a Deputy Director of Center of Research in Biotechnology for Agriculture (CEBAR) in University of Malaya
MicroRNAs (miRNAs) have been well documented to regulate various cancer phenotype. Research into the specific roles of several miRNAs and their target genes involved in apoptosis, angiogenesis, anoikis...
  SPC and Evaluation of Analyst Performance
Mostafa Essam , Independent PhD researcher and Candidate, Faculty of Pharmacy, Cairo University
SPC are vital tool to monitor the quality of specific characteristics. They can show abnormal trends in data even if results were within the acceptance criteria. Accordingly, the evaluation of the analysts and the...
Lonza
Techno Trends
 Pfizer Launches Janus Kinase 3 (JAK3) Inhibitor PF-06651600
 Insmed Announces ARIKAYCE® For the Treatment of Mycobacterium...
Medical Fair Thailand
Projects
  Novo Nordisk to Establish Manufacturing Site in California
 Bioanalytical Systems, Inc (BASi) Plans to Expand its GLP Toxicology...
 Vetter Pharma
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555